Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature

Frontiers in Nutrition

Nutrition

Brunella Capaldo¹  Elena Massimino¹  Anna Paola Amoroso¹  Roberta Lupoli²  Alessandro Rossi³ 

[1] Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy;Department of Molecular Medicine and Medical Biotechnology, University Federico II, Naples, Italy;Department of Translational Medicine, Section of Pediatrics, University Federico II, Naples, Italy;

关键词: glycogen storage disease;    dietary intervention;    high-fat diet;    cardiomyopathy;    myopathy;    continuous glucose monitoring (CGM);   

DOI  :  10.3389/fnut.2023.1178348

 received in 2023-03-02, accepted in 2023-04-13,  发布年份 2023

来源: Frontiers

【 摘 要 】

Glycogen storage disease Type III (GSD III) is an autosomal recessive disease due to the deficiency of the debranching enzyme, which has two main consequences: a reduced availability of glucose due to the incomplete degradation of glycogen, and the accumulation of abnormal glycogen in liver and cardiac/skeletal muscle. The role of dietary lipid manipulations in the nutritional management of GSD III is still debated. A literature overview shows that low-carbohydrate (CHO) / high-fat diets may be beneficial in reducing muscle damage. We present a 24-year GSD IIIa patient with severe myopathy and cardiomyopathy in whom a gradual shift from a high-CHO diet (61% total energy intake), low-fat (18%), high-protein (21%) to a low-CHO (32 %) high-fat (45%) / high-protein (23%) diet was performed. CHO was mainly represented by high-fiber, low glycemic index food, and fat consisted prevalently of mono and polyunsaturated fatty acids. After a 2-year follow-up, all biomarkers of muscle and heart damage markedly decreased (by 50–75%), glucose levels remained within the normal range and lipid profile was unchanged. At echocardiography, there was an improvement in geometry and left ventricular function. A low -CHO, high-fat, high-protein diet seems to be safe, sustainable and effective in reducing muscle damage without worsening cardiometabolic profile in GSDIIIa. This dietary approach could be started as early as possible in GSD III displaying skeletal/cardiac muscle disease in order to prevent/minimize organ damage.

【 授权许可】

Unknown   
Copyright © 2023 Massimino, Amoroso, Lupoli, Rossi and Capaldo.